New Alzheimer’s drug approved in the US
The US Food and Drug Administration (FDA) grants expedited approval to Biogen to market its Alzheimer’s drug in the US. The…
biotechnology
Starting in June, big change at Roche Polska
As of 1 June 2021, the position of General Manager of Roche Poland will be assumed by Irma Veberic, who…
Pharmaceutical companies invest in Poland
Bayer has announced plans to launch its Digital Hub in Poland. The unit is to be launched in July this…
Vatnak Vat-Ho as Chief Business Officer at Ryvu Therapeutics
Ryvu Therapeutics S.A., one of Europe’s largest innovative biotechnology companies active in the discovery and development of new oncology therapies,…
Selvita with a permit for the construction of a Laboratory Services Centre
Selvita S.A. has received permission from the President of the City of Krakow to build a Research and Development Centre…
Sano and NEO Hospital to develop new health technologies
NEO Hospital and Sano Centre for Computational Personalised Medicine have established a collaboration. Under the agreement, the units will work…
Captor Therapeutics: Dr Tom Shepherd appointed President of the Management Board
Captor Therapeutics, a biopharmaceutical company working to develop drugs for cancer and autoimmune diseases, has announced the appointment of President…
Selvita acquires in Croatia
Selvita, which specialises in laboratory research and development services for external customers, has announced the conclusion of its first acquisition…
Bioton: Jeremy Launders as President of the Management Board
Robert Neymann has resigned from the position of President of the Management Board at Bioton. Although his term of office…
Ryvu Therapeutics: Three drugs in clinical trials
Ryvu Therapeutics (formerly Selvita), a Polish biotechnology company, is expanding its plans for R&D projects. By the end of 2022,…
